Company Description
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.
It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line.
The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts.
The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021.
Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
| Country | United States |
| Founded | 1974 |
| IPO Date | Nov 24, 1997 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 2,075 |
| CEO | Robert Leasure |
Contact Details
Address: 2701 Kent Avenue West Lafayette, Indiana 47906 United States | |
| Phone | 765 463 4527 |
| Website | inotiv.com |
Stock Details
| Ticker Symbol | NOTV |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000720154 |
| CUSIP Number | 45783Q100 |
| ISIN Number | US45783Q1004 |
| Employer ID | 35-1345024 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Robert W. Leasure Jr. | President, Chief Executive Officer and Director |
| Beth A. Taylor CPA | Senior Vice President of Finance and Chief Financial Officer |
| Dr. John E. Sagartz D.V.M., DiplomateACVP, Ph.D. | Chief Strategy Officer and Director |
| Brennan Freeman | Vice President of Finance, Principal Accounting Officer and Corporate Controller |
| Andrea Castetter | SVice President of General Counsel, Corporate Secretary and Chief Compliance Officer |
| Jeffrey Arthur Krupp | Chief Human Resources Officer |
| John Gregory Beattie DSA | Chief Operating Officer of DSA |
| Dr. Adrian Hardy Ph.D. | Chief Commercial Officer |
| Lizanne Muller | Group President of RMS |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 18, 2025 | 424B7 | Filing |
| Jun 4, 2025 | 8-K | Current Report |
| Jun 2, 2025 | 144 | Filing |
| May 29, 2025 | 8-K | Current Report |
| May 8, 2025 | 10-Q | Quarterly Report |
| May 7, 2025 | 8-K | Current Report |
| Apr 1, 2025 | 144 | Filing |
| Mar 13, 2025 | 8-K | Current Report |
| Mar 13, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 18, 2025 | 8-K | Current Report |